10. February 2021

Portfolio expansion of the Rieker Finanz-Gruppe

OPPENLÄNDER Rechtsanwälte advised Rieker Investment GmbH on its acquisition of a majority holding in the WM Beautysystems group. The WM Beautysystems group is the largest beauty and tanning studio chain operator in Germany and Europe, running its studios under the well-known brand Sunpoint. WM Beautysystems currently owns 115 studios and 80 franchise studios. The selling shareholder will continue to hold a minority stake in WM Beautysystems group and will continue to support the WM Beautysystems group.

Rieker Investment GmbH is a subsidiary of Rieker Finanz-Gruppe. Rieker Finanz-Gruppe is an independent segment of Rieker-Gruppe, which also includes the shoe manufacturer Rieker Schuh. Rieker Finanz-Gruppe is focused on long term investments in medium sized enterprises of various sectors. The investments of Rieker Finanz-Gruppe continue to be operated independently by the existing management.

OPPENLÄNDER Rechtsanwälte advised Rieker Finanz-Gruppe comprehensively in connection with the transaction. The following team was led by Dr. Felix Born (Partner): Dr. Malte Weitner (Partner, IP/IT/Commercial), Dr. Christian Gunßer (Partner, Corporate/M&A/Commercial), Dr. Ulrich Klumpp (Partner, Antitrust), Dr. Natalie Seitz (Antitrust), Dr. Kalina Haack (Corporate/M&A), Dr. Daniel Schillerwein (Corporate/M&A), Arthur Eichmann (Corporate/M&A) and Marius Bücke (HR).

The management of Rieker Finanz-Gruppe, Thomas Guhl and Axel Wiehrer, implemented the transaction in house.

Dr. Felix Born

+49 (0)711 60187-232
born@oppenlaender.de

Dr. Ulrich Klumpp

+49 (0)711 60187-172
klumpp@oppenlaender.de

Dr. Christian Gunßer

+49 (0)711 60187-162
gunsser@oppenlaender.de

Dr. Malte Weitner

+49 (0)711 60187-176
weitner@oppenlaender.de

Dr. Natalie Seitz

+49 (0)711 60187-240
natalie.seitz@oppenlaender.de

Arthur Eichmann

+49 (0)711 60187-244
arthur.eichmann@oppenlaender.de

More news

All news

13. May 2026

OPPENLÄNDER wins lawsuit regarding claims for damages arising from pharmaceutical rebate contracts

Dr Matthias Ulshöfer and Dr Joachim Ott have successfully defended an international pharmaceutical company against unjustified claims for damages arising from pharmaceutical rebate contracts in a landmark case before the Munich Social Court. The actions brought by a major statutory health insurance fund were dismissed by way of a “judgment from the bench”.

01. April 2026

OPPENLÄNDER overturns minimum fares for ride-hailing services in Essen in a landmark case for BOLT

Dr. Henrike Schulte and Dr. Maximilian Gerhold of OPPENLÄNDER successfully secured a stay of a general administrative act issued by the City of Essen regarding minimum fares for ride-hailing services before the Administrative Court of Gelsenkirchen, acting on behalf of the European mobility platform BOLT and a Dortmund-based ride-hailing company.

12. February 2026

OPPENLÄNDER is once again among the best according to Legal500

In the recently published ranking of Legal 500 Germany 2026, we are once again a TOP LAW FIRM in the City Focus Stuttgart and are ranked as a TOP TIER LAW FIRM in two practice areas.

29. January 2026

OPPENLÄNDER Rechtsanwälte wins dispute over functional allowances for the Saarland state parliament

Prof. Dr. Christofer Lenz and Dr. Maximilian Gerhold successfully defended the Saarland state parliament against a constitutional complaint filed by an AfD member of parliament regarding the functional allowances for parliamentary secretaries and deputy faction leaders.